🔴 Inovio Pharmaceuticals is trading 5% down — no clear catalyst identified

Inovio Pharmaceuticals is trading 5.22% down at $1.09, with no clear catalyst identified for the October 12 decline.

• The FDA’s October 30 decision date for INO-3107 was previously reported, but does not establish the cause of this session’s move.
• Broader indexes are mixed and reported biotech ETF moves are modest, with no clear market-wide explanation evident.